Pradaxa

Pradaxa (dabigatran) is an anticoagulant medication used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation. It also treats and prevents deep vein thrombosis (DVT) and pulmonary embolism (PE).

Benefits of Pradaxa:

• Reduces the risk of stroke and blood clots in atrial fibrillation patients.
• Prevents and treats DVT and PE.
• Provides a convenient oral alternative to traditional blood thinners.

Dosage:

• Typical dose: 150 mg twice daily for stroke prevention.
• Maintenance dose: As prescribed by your healthcare provider.

Warnings and Precautions:

• Monitor for signs of bleeding, as Pradaxa increases the risk of bleeding complications.
• Use with caution in patients with kidney impairment.
• Regular blood tests may be required to monitor kidney function.

Usage Instructions:

• Take Pradaxa with or without food, as directed by your doctor.
• Swallow the capsules whole with a glass of water.
• Do not crush, chew, or open the capsules.

Storage Information:

• Store at room temperature, between 68°F and 77°F (20°C to 25°C).
• Keep it in its original container, away from moisture and light.

Common Side Effects:

• Bleeding and bruising.
• Indigestion and stomach discomfort.
• Allergic reactions.

More information about Praxada:

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide